Onglyza cost should be assessed for the prescribed 2.5- or 5-mg tablet and the product the pharmacy can dispense. Dose selection may reflect kidney function or interactions, so price is not a reason to exchange strengths.
Quote the current prescription
Provide the tablet strength, quantity and supply period, and ask whether the claim uses branded Onglyza or another permitted saxagliptin product. A search result naming the ingredient does not itself establish generic stock or the plan’s payment. The pharmacist should identify the actual product behind the quote.
Explain a changed strength to the pharmacy
If the clinician changes the dose after a kidney review or a new interacting medicine, make sure the old order is not being refilled. Ask whether the authorization or refill calculation must be updated. A claim for the previous strength can produce an irrelevant price or an avoidable rejection.
Check product-specific formulary rules
Ask the plan about the exact saxagliptin product, any authorization and the reason for a rejection. Another DPP-4 inhibitor may have a different tier, but it is also a different medicine. Have the prescriber assess any proposed alternative, particularly where heart failure or kidney impairment is relevant.
Confirming current manufacturer support
Before relying on a savings offer, ask whether Onglyza is currently included and whether your insurance and prescription qualify. Check benefit limits and expiry dates. An older offer or a program for another AstraZeneca medicine does not establish current support for saxagliptin.
Source: [2]
Separate medicine payment from monitoring
The cost of tablets does not include all visits or laboratory follow-up. Ask for the actual insured payment and, if useful, a matching cash quote, with any deductible implications explained. Tell the clinical team early if an access problem would interrupt treatment or monitoring.
Questions and answers
Can I change strength to match a cheaper listing?
No. The strength may be required by kidney function or interactions.
Does an old AstraZeneca coupon prove current Onglyza support?
No. Verify current participation for Onglyza itself.
What if the plan prefers another DPP-4 inhibitor?
The prescriber should assess suitability and provide a new prescription before the alternative’s cost is treated as actionable.
Related reading
Sources
- Onglyza: official US prescribing information
- HealthCare.gov: prescription coverage, formularies and exceptions
- FDA: generic drug facts
Sources checked 1 October 2026. This information does not replace advice from your healthcare professional. For complete warnings and instructions, read the product information and consult the prescribing team.
Reviewed by: Mattias Hagman, PhD
About the reviewer:
Dr Mattias Hagman (PhD, University of Sydney) has an academic background and experience working with healthcare-related content and regulated industries. He has lecturing experience at international universities, including Stockholm University and the University of Malta.
Last reviewed: October 2026